This is a preview of subscription content, log in via an institution to check access.
Notes
2019 US dollars
Reference
Siddiqui K, et al. Cost-Effectiveness of Rifaximin-alpha versus Lactulose in preventing recurrent episodes of overt hepatic encephalopathy: a systematic review and meta-analysis. The International Liver Congress 2021 : abstr. PO-2608, 23 Jun 2021. Available from: URL: https://easl.eu/event/the-international-liver-congress-2021/
Rights and permissions
About this article
Cite this article
Rifaximin cost effective in hepatic encephalopathy. PharmacoEcon Outcomes News 886, 20 (2021). https://doi.org/10.1007/s40274-021-07998-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-07998-6